GenVault, Corp.: Series C $13M

Posted in I - Series C, Q - 2Q08, R - WEST, X - Sample Storage, X - Sample Transport

GenVault (Carlsbad, CA) focused on room temperature biosample management, closed a $13M Series C financing. Participants included Montagu Newhall Associates, Domain Associates, QuestMark Partners and Cross Creek Capital.

Gemin X Pharmaceuticals, Inc.: Series C $38M

Posted in I - Series C, Q - 2Q08, R - NORTH EAST, X - Oncology

Gemin X Pharmaceuticals (Malvern, PA) focused on developing novel treatments for cancer, closed a $38M Series C financing. Participants include Caxton Advantage Life Sciences Fund, Caxton Global, Sanderling Ventures, H.I.G. Ventures, CDP/Vantage Point, ProQuest, Merlin BioMed Group, HBM Partners, Canadian Medical Discoveries Fund, Ontario Teachers’ Pension Plan Board, SoftBank Life Science, Business Development Bank [...]

Syndexa Pharmaceuticals, Corp.: Series B $15M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Metabolism

Syndexa Pharmaceuticals (Cambridge, MA) a metabolic drug discovery company, closed a $15M Series B financing. Participants include Yalcin Ayalsi.

Rox Medical, Inc.: Series C $35M

Posted in I - Series C, Q - 2Q08, R - WEST, X - COPD, X - Device (Cardiology)

Rox Medical (San Clemente, CA) medical device company focused on chronic obstructive pulmonary disease, closed a $35M Series C financing. Participants include Essex Woodlands Health Ventures, Domain Associates, Prism VentureWorks and Versant Ventures.

PhysioSonics, Inc.: Series A $4M

Posted in I - Series A, Q - 2Q08, R - NORTH WEST, X - Neurology

PhysioSonics (Seattle, WA) a developer of noninvasive neurologic products, closed a $4M Series A financing. Participants include Johnson & Johnson Development Corp.

Oncodesign, SA: Series B $4.7M

Posted in I - Series B, Q - 2Q08, R - INTERNATIONAL, X - CRO

Oncodesign (France) a CRO and provider of preclinical oncology services, closed a $4.7 million Series B financing. Participants include Vizille Capital Innovation and Avenir Enterprises.

TelaDoc Medical Services, Inc.: Series A $3M

Posted in I - Series A, Q - 2Q08, R - SOUTH WEST, X - TeleMedicine

TelaDoc Medical Services (Dallas, TX) a commercial stage company focused on providing around-the-clock access to telephone consults with primary care doctors who diagnose medical problems and prescribe medication, closed a $3M Series A financing. Participants include Trident Capital.

China Medicine On-Line, Ltd.: Series A $8M

Posted in I - Series A, Q - 2Q08, R - INTERNATIONAL, X - TeleMedicine

China Medicine On-Line (China) focused on building a nation-wide integrated network to provide tele-homecare and tele-healthcare services, closed an $8M series A financing. Participants include Infinity I-China Fund.

Inimex Pharmaceuticals, Inc.: Series B $22M

Posted in I - Series B, Q - 2Q08, R - INTERNATIONAL, X - Immunology

Inimex Pharmaceuticals (Canada) developer of medicines that use selective modulation of the innate immune response, closed a $22M Series B financing. Participants include Morningside Venture Investments, Astellas Venture Management, Advantage Life Science Fund, BC Advantage Funds, BDC Capital, British Columbia Discovery Fund, Canadian Medical Discovery Fund and Working Opportunity Fund.

Sinexus, Inc.: Series B $20M

Posted in I - Series B, Q - 2Q08, R - WEST, X - Device (ENT)

Sinexus (Palo Alto, CA) developer of medical devices for the treatment of chronic sinusitis, closed a $20M Series B financing. Participants include PTV Sciences, Kleiner Perkins Caufield & Buyers and U.S. Venture Partners.

« Previous Entries

to top of page...